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Abstract T cell receptor (TCR) nucleotide sequences are
often generated during analyses of T cell responses to
pathogens or autoantigens. The most important region of
the TCR is the third complementarity-determining region
(CDR3) whose nucleotide sequence is unique to each T cell
clone. The CDR3 interacts with the peptide and thus is
important for recognizing pathogen or autoantigen epitopes.
While conventions exist for identifying the various TCR
chains, there is a lack of a concise nomenclature that would
identify both the amino acid translation and nucleotide
sequence of the CDR3. This deficiency makes the
comparison of published TCR genetic and proteomic
information difficult. To enhance information sharing
among different databases and to facilitate computational
assessment of clonotypic T cell repertoires, we propose a
clonotype nomenclature. The rules for generating a clono-
type identifier are simple and easy to follow, and have a
built-in error-checking system. The identifier includes the V
and J region, the CDR3 length as well as its human or
mouse origin. The framework of this naming system could
also be expanded to the B cell receptor.
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Introduction
A hallmark of immunity is the intrinsic ability to recognize
and eliminate foreign molecules, cells, and organisms. The
adaptive immune system is comprised of B and T cells.
During Tand B cell development these cells express unique
heterodimeric receptors that can be used in pathogen
recognition. Each of these receptor chains is generated by
a somatic rearrangement process that joins different seg-
ments of the TCR and BCR genes and creates a novel gene.
This joining process is imprecise with insertion of non-
templated nucleotides (N nucleotides) in the junction site,
as well as 3′- and 5′-nucleotide deletion from the germline
genes participating in the rearrangement. This region of
random nucleotide insertion or deletion referred to as the
third complementarity-determining region (CDR3). The
resulting CDR3 have a unique nucleotide sequence that is
specific to that particular B or T cell and all its progeny;
hence, the clonotypic nature of the receptors. The CDR3 is
the portion of these receptors that is most involved in
interactions with intact soluble antigens (B cells) or
intracellular processed antigens presented as immunogenic
peptides loaded in MHC molecules (T cells)
The initial phase of the adaptive immune responses
involves B and T cell clonal selection on the basis of the
structural complementarity of antigen-specific receptors to
pathogen-derived epitopes (Davis and Chien 2003; Kolar
and Capra 2003). The cells recruited into the immune
response execute their effector function role. After patho-
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memory. Memory provides more rapid and effective
immune protection against recurring pathogen present in
the environment. The collection of cells that respond to a
particular pathogen is referred to as the repertoire.
T and B cells can also be implicated in responses to non-
pathogenic environmental stimuli (allergies). More serious
is the lack of tolerance to self that results in responses to
self-antigens giving rise to autoimmune disease. In each
case, a repertoire of allergen- or self-specific B or T cells is
generated.
The repertoire recognizing a molecule would be a sum of
the repertoires responding against all the component
epitopes of the molecule. The repertoire against an
organism would be the sum of all the repertoires against
all the molecules from the pathogen.
Measuring an immune response at the level of the
repertoire is becoming very common (Correia-Neves et al.
2001; La Gruta et al. 2008; Naumov et al. 1998; Pewe et al.
2004; Probert et al. 2007; Venturi et al. 2008). An antigen-
specific response can be viewed in the context of how many
T cells are recruited and the structure of their antigen
receptors. The nature of the naïve and antigen-experienced
cells repertoire is of interest in basic and clinical immunol-
ogy, immune-pharmaceutics, and vaccine development.
However, comparison of datasets from similar, or even
identical, experiments from different laboratories is cum-
bersome due to lack of the unified clonal identification
procedure where the clonotypic antigen-receptor serves a
marker of clonal identity. Having a quick way to assign
specific identifiers for specific receptor sequence would
facilitate such comparison studies.
There are two subsets of T cells based on the exact pair
of receptor chains expressed. These are either the alpha (α)
and beta (β) chain pair, or the gamma (γ) and delta (δ)
chain pair, identifying the αβ or γδ Tc e l ls u b s e t s ,
respectively. The expression of the β and δ chain is limited
to one chain in each of their respective subsets and this is
referred to as allelic exclusion (Bluthmann et al. 1988;
Uematsu et al. 1988). These two chains are also character-
ized by the use of an additional DNA segment, referred to as
the diversity (D) region during the rearrangement process.
The D region is flanked by N nucleotides which constitutes
the NDN region of the CDR3 in these two chains.
The CDR3 of each of the two receptor chains defines the
clonal specificity. For αβ T cells the CDR3 is in most
contact with the peptide bound to the MHC (Rudolph et al.
2006). For this reason, CDR3 sequences have been the
main focus for sequencing studies. In the past three
decades, TCR clone sequences have been presented in
publications in many different forms. Some, using an alias
as an identifier and present a whole nucleotide sequence of
a clone by identifying the V, D, and J segments (Elliott et
al. 1988). In some publications, the information about the V
and the J usage and the amino acids of the V/NDN/J
junction sequences (Kent et al. 2005) are given, while in
other publications, both nucleotides and amino acid
sequences of all different segments that have been
recombined to make up the CDR3 region of the TCR
clones are given (Maslanka et al. 1996; Naumov et al.
1998; Shin et al. 2005). However, a full sequence could be
quite bulky. Often, for simplicity, each sequence is assigned
its own alias that could be a number or a combination of
letters and numbers to ease the tracking of information
(Cameron et al. 2002; Chien et al. 1987; Correia-Neves et
al. 2001; Davis and Bjorkman 1988; Elliott et al. 1988;
Kalams et al. 1994; La Gruta et al. 2008; Lehner et al.
1995; McHeyzer-Williams and Davis 1995; Naumov et al.
1998, 2006; Pewe et al. 2004; Venturi et al. 2008). With the
arrival of new ultra-high throughput or massively parallel
sequencing techniques these data sets are bound to grow
larger. Without a proper standardization, the general
compilation of such information across published and
documented data sources is problematic. Thus, there is a
need for a nomenclature which allows to properly enumer-
ating the TCR chains and tracing them to the T cell clones.
The primary purpose of this naming system is to have a
unique identifier for the CDR3 of each TCR chain, so that
information about the T cell clones in publications, data-
bases, and other forms of communication can be unambig-
uously associated with the correct T cell clone. The
proposed nomenclature is intended to provide the immu-
nology community an easy route to share genetic informa-
tion about clonal and clonotypic T cell receptors.
Materials and methods
T cell clonotypes
To properly document and enumerate TCR CDR3, we have
developed a working definition of a clonotype and a
nomenclature that reflects the sequence information of the
CDR3 of that particular receptor:
1. A TCR clonotype is a unique nucleotide sequence that
arises during the gene rearrangement process for that
receptor. The combination of nucleotide sequences for
the surface expressed receptor pair would define the T
cell clonotype.
2. Clonotyping is a process to identify the unique
nucleotide CDR3 sequences of a TCR chain. This
generally involves PCR amplification of the cDNA
using V-region-specific primers and either constant
region (C) specific or J-region-specific primer pairs,
followed by nucleotide sequencing of the amplicon.
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identifiers and tracing records of clonotype identification.
The clonotype nomenclature
The clonotype nomenclature refers to a system of names
that are fully controlled through explicit and rigid syntactic
rules. We have also defined a list of desired features for a
clonotype identifier that allows computational assignment.
To minimize the identifier length and to maintain clarity a
mix of letters and digits is used. There is a firm restriction
on the use of capitalization and character formatting in a
formal name. For the clonotype nomenclature, lowercase
letters are reserved for amino acid sequences in the Vand J
regions and uppercase letters are reserved for amino acid
sequences in the region between the V and J. Thus, the
uppercase corresponds to amino acids encoded by the N or
NDN regions. To make names fully computable, we are
avoiding the use of subscripts, superscripts, accents, and
word separators; Greek symbols are replaced by uppercase
Roman letters; the period (‘.’) is used as a symbol separator.
The clonotype-naming process
The name contains information on amino acid sequence
originating from V, J, and NDN regions. The name consists
of five segments: (1) CDR3 amino acid identifier, (2)
CDR3 nucleotide sequence identifier, (3) variable (V)
segment identifier, (4) joining (J) segment identifier, and
(5) CDR3 length identifier. The name can be constructed
and deconstructed in the same manner. Access to a standard
genetic code table and the germline configuration of the V
and J regions identified in the name is all that is needed to
reconstruct the actual nucleotide sequence of the clonotype.
The rules for clonotype naming are as follows:
1. CDR3 amino acid identifier
This segment uses the one-letter code and always starts and
ends with a lowercase letter. The starting lowercase letter
represents the last amino acid from the V segment which is
completely (all three nucleotides) encoded from the V region.
Thefinallowercaseletterrepresentsthefirstaminoacidentirely
encoded by the J region. Uppercase letters represent amino
acids that are encoded fully or in part by the NDN region.
2. Nucleotide sequence identifier (ID)
A series of digit numbers (ID) with a leading period for a
symbol separator is reserved for a nucleotide identifier.
Each digit in this number reflects the specific codon for
each uppercase amino acid in the name. These numbers are
not limited and appear in the same order as their amino acid
counterparts. The identifier assignment is based on the
standard codon table (Table 1). The codons for each amino
acid are numbered sequentially from top to bottom and then
across and down for the six codon amino acids. The three
termination codons are assigned “O” and numbered 1 for
Ochre (TAA), 2 for Amber (TAG), and 3 for Opal (TGA).
The letter “O” is chosen because two of the three
terminators start with this letter and no amino acid is
associated with this letter.
3. TCR V region identifier
The V gene family (also referred to as group) is
identified by an uppercase Roman letter followed by a
TCA G
T TTT F 1 TCT S 1 TAT Y 1 TGT C 1
TTC F 2 TCC S 2 TAC Y 2 TGC C 2
TTA L 1 TCA S 3 TAA Ochre=O 1 TGA Opal=O 3
TTG L 2 TCG S 4 TAG Amber=O 2 TGG W 1
C CTT L 3 CCT P 1 CAT H 1 CGT R 1
CTC L 4 CCC P 2 CAC H 2 CGC R 2
CTA L 5 CCA P 3 CAA Q 1 CGA R 3
CTG L 6 CCG P 4 CAG Q 2 CGG R 4
A ATT I 1 ACT T 1 AAT N 1 AGT S 5
ATC I 2 ACC T 2 AAC N 2 AGC S 6
ATA I 3 ACA T 3 AAA K 1 AGA R 5
ATG M 1 ACG T 4 AAG K 2 AGG R 6
G GTT V 1 GCT A 1 GAT D 1 GGT G 1
GTC V 2 GCC A 2 GAC D 2 GGC G 2
GTA V 3 GCA A 3 GAA E 1 GGA G 3
GTG V 4 GCG A 4 GAG E 2 GGG G 4
Table 1 Genetic codes and their
assigned ID numbers
ID numbers are assigned to the
codons for each amino acids in
the codon table by numbering
sequentially from top to bottom
and across giving “1” for the
first sequence that coded any
amino acid and “2” for the
second sequence that coded the
same amino acid and so on. The
termination sequences are
assigned the letter “O”. The
letter “O” is used because none
of the one letter amino acid
codes are represented as “O”.I D
number of “1” is assigned to the
first termination code TAA
(Ochre, O1), and 2 for the TAG
(Amber, O2), and 3 for the TGA
(Opal, O3)
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In order to sort the clonotypes based on the V gene usage
we assign a fixed number of characters for the V gene
subfamilies. The names of the human V gene subfamilies
are as originally described by Hood and colleagues (Rowen
et al. 1996). Each V gene is assigned a subfamily number
(two digits) followed by S and another number to define the
subfamily member. In the case of TCR AV and TCR BV
genes, some subfamilies have more than one member. The
members are identified by S1, S2, S3, … for human and
−1, −2, −3, … for mouse. The names of the mouse V genes
are based on the ImMunoGeneTics (IMGT) database
(Giudicelli et al. 2005). For mouse distal V alpha genes
that are repeats of the proximal ones, we omitted the “–” in
the name to keep the total characters to five, similar to that
for human V genes. The breakdown of the assigned
characters is shown in Table 2.
The identification of a subfamily member from a TCR
sequence focused on the CDR3 depends on the specificity
of the V region primer and the sequence homology of the
subfamily members in the DNA segment 3′ of the V primer.
If the primer is specific enough to distinguish a specific
subfamily member, the clonotype name will have the
specific subfamily member’s name. If the primer pairs to
the region that all subfamily members have identical
sequences, then the DNA sequence 3′ of the primer will
determine the TCRV name. If all subfamily members have
identical sequence for this region, the subfamily member’s
name will be SX for human, and −X for mouse. If some
family members can be defined but others cannot, the
indistinguishable subfamilies are referred to using Y and Z.
The possible members that comprise Y and Z should be
further explained.
Some AV genes can rearrange to either alpha J genes
(resulting in a TCR alpha chain) or delta J genes (resulting
in a TCR delta chain). These are called ADV genes. Based
on their location in the AV locus region, we simplify the
nomenclature by using the alpha gene name. The J region
identifier then specifies to which constant region the VA is
linked. Shown in Table 3 are the human and mouse alpha/
delta genes and our corresponding nomenclature. There are
two genes that do not follow this rule; the human delta V1
gene which is located between the AV23 and AV24 genes
only rearranges to the delta J genes and yet has not been
found rearranging to alpha J genes, and mouse AV15-2/
DV6-2 and AV15D-2/DV6-2 genes are similar and yet have
not been found rearranging to the alpha J genes. In our
naming system, the delta V name will be used for these
genes; D1 for human and D6-2 for mouse.
Allelic forms of V regions exists (http://imgt.cines.fr/
textes/IMGTrepertoire/Proteins/#B). Currently, the clono-
type nomenclature does not account for these. They could
be identified by enlarging the V region identifier by one or
two characters. The need for this level of characterization is
unclear at this time so the identifier has been kept shorter
for sake of usability.
4. TCR J region identifier
The J gene identifier appears after the V gene identifier.
The J gene family is expressed by Roman letters as defined
for the V gene identifier above. Human (Rowen et al. 1996)
and mouse (Giudicelli et al. 2005) J genes are named as
described. For sake of brevity and to facilitate sorting, the
“S” for designation of subfamily members in human and
the “−” for designation of the subfamily members for
mouse is dropped, resulting in a two-digit number. The
detail of J character assignment is shown in Table 4.I t
should be noted that there are five subfamily in human
gamma J family; 1, 2, P, P1, and P2, that two of the
subfamilies have been identified by assigned numbers
(gamma J1 and gamma J2), one has a been identified by
assigned letter (gamma JP) and two have been identified by
a letter and a number (gamma JP1 and gamma JP2). In
order to have the same characters for all human gamma J
genes, we are assigning a number to the ones that do not
have a number identifier as follows; GJP = GJ3, GJP1 =
GJ4, and GJP2 = GJ5.
There are a number of alleles of J regions that have been
reported (Lefranc and Lefranc 2001 & http://imgt.cines.fr/
textes/IMGTrepertoire/Proteins/#B). Currently, the nomen-
Table 2 Breakdown of assigned characters for human and mouse V genes in clonotype identifier
TCR TCR chain
assigned ID
Human V gene characters
(No.) letter (No.)
Human V gene
overall characters
Mouse V gene characters
(No.) "− "or letter (No.)
Mouse V gene
overall characters
TCR α A (2 digit) S (1 digit) 5 (2 digit) “−“ or “D” (1 digit) 5
TCR β B (2 digit) S (1 digit) 5 (2 digit) “−“ (1 digit) 5
TCR γ G (2 digit) 3 (1 digit) 2
TCR δ D (1 digit) 2 (1 digit) “−“ (1 digit) 4
Column one represents the TCR chain. Column two represents the human V characters and their placeholders. For example, the V04S1 is
displayed as 04S1 that has two digits (04) and the letter (S), and the 1 digit (1). Column three represents the overall human V gene characters, for
example the 5 for B04S1. Columns four and five represent the same for mouse V genes in the clonotype identifier
496 Immunogenetics (2009) 61:493–502clature does not take these into account. If needed, the J
identifier could be extended by one character to include an
allele identifier.
5. CDR3 length identifier
The length of the clonotype is determined by the number
of amino acids between the C-terminal-conserved cysteine
(C) of the V region, and phenylalanine (F) of the J region
which is part of the FG×GT conserved motif in all J
regions. The C and the F are not counted in the length. The
number representing the length is preceded by a letter L
that serves as a symbol separator. In order to sort the
clonotypes based on their length, we assigned three
characters for the length, the first being the letter “L”,
followed by the two digits specifying the length.
Results and discussion
Generating a TCR clonotype identifier The use of the
nomenclature is demonstrated for a TCR β-chain clonotype
from our studies of CD8 T cells from HLA-A2.1 individ-
uals responding against the influenza A matrix protein M1-
derived peptide, M158–66 (Fig. 1). The nucleotide sequence
is shown in the center with the amino acid translation
underneath. The nucleotides corresponding to the NDN
region are bold and underlined. The last amino acid which
is completely encoded from the V gene (agt) is Serine, so
the clonotype name will start with lowercase letter “s”.
Amino acids in the NDN region (IRSS) are presented as
uppercase letters. It should be noted that I is partially
encoded by the V gene and the second S is partially
encoded by the J gene. The first amino acid which is
completely encoded from the J gene is Tyrosine (tac) and is
denoted as a lowercase “y”. A period is used as a symbol
separator between the amino acid identifier and the
nucleotide identifier. Each uppercase letter in the NDN
region (IRSS) gets a nucleotide identifier number based on
the codon table (Table 1). An Ile that is encoded by ATT
gets number 1, Arg that is encoded by CGG gets number 4,
Ser that is encoded by AGT gets number 5, and Ser that is
encoded by AGC gets number 6. In this case, the four-digit
numbers “1456” identifies the nucleotide sequence of NDN
region (atT, CGG, AGT, AGc). The origin of the V gene is
expressed by B for beta, followed by the subfamily19 and
subfamily member S1. The “S” in the V region identifier
indicates that the clonotype is derived from human T cell.
The origin of the J gene is shown by B for beta and
subfamily 2 and the subfamily member 7. The length of the
clonotype is the number of amino acids between the
Table 3 Human and mouse α/δ gene assignment
Human alpha/delta v genes
(by Rowen et al.)
Human assigned V name
(proposed nomenclature)
Mouse alpha/delta V genes
(by IMGT)
Mouse assigned V name
(proposed nomenclature)
hADV14S1 A14S1 AV4-4/DV10 A4-4
hADV23S1 A23S1 AV6-7/DV9 A6-7
hADV29S1 A29S1 AV13-4/DV7 A13-4
hADV36S1 A36S1 AV14D-3/DV8 A14D3
hADV38S2 A38S2 AV15-1/DV6-1 A15-1
AV16D-1/DV11 A16D1
AV21-1/DV12 A21-1
Column one represents the Human α/δ V gene names based on (Rowen et al. 1996). Column two represents the human α/δ V gene names
assigned by the present nomenclature. Column three represents the mouse α/δ V gene names based on IMGT nomenclature. Column four
represents the mouse α/δ V gene names assigned by the present nomenclature.
Table 4 Breakdown of assigned characters for human and mouse J genes in clonotype identifier
TCR TCR Chain
assigned ID
Human J Gene
Characters (No.)
Human J Gene
Overall Characters
Mouse J Gene
Characters (No.)
Mouse J Gene
Overall Characters
TCR α A (2 digit) 3 (2 digit) 3
TCR β B (2 digit) 3 (2 digit) 3
TCR γ G (1 digit) 2 (1 digit) 2
TCR δ D (1 digit) 2 (1 digit) 2
Column one represents the TCR chain. Column two represents the human J characters which is number and their place holders that are 2. For
example, J2S1 is displayed as 21 (two digits). Column 3 represents the overall human J gene characters for example B21. Columns 4 and 5
represent the same for mouse J genes in the clonotype identifier
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region which is part of FG×GT, which in this case is 11.
Thus, the length identifier is the letter “L” for length
followed by number 11.
It should be noted that the example shown here does not
account for allelic differences in the V or the J genes. An
example of the same clonotype identifier with the J allele
information would be sIRSSy.1456B19S1B271L11, with
the first two digits of the J identifier specifying the
subfamily member (2S7) and the final digit specifying the
allele.
V region nomenclature For TCRAV and TCRBV, some BV
subfamilies have more than one member. The identification
of the subfamily members depends on two factors. The first
is the specificity of the V region primer that is used for
amplifying the particular V subfamily member. Primers could
be designed that are specific for only one subfamily member.
If the primer is specific enough to anneal only to one of the V
subfamily members, then the clonotype identifier will use the
subfamily member’sn a m es u c ha sS 1 ,S 2 ,S 3( f o rh u m a n ) ,
and −1, −2, −3( f o rm o u s e ) .T h es e c o n df a c t o ri st h e
sequence homology between the subfamily members in the
region 3′ of the V primer up to the conserved cysteine,
the nucleotide differences downstream the conserved cysteine
is not considered due to possibility of excision during the
rearrangement process. For some choices of primer, there
may be sufficient differences in the region between the
primer and the conserved cysteine that the particular
subfamily member can be identified. If this is the case, then
the name of subfamily member is used. In other cases, the
sequence between the V primer and the conserved cysteine is
associated with multiple sequences. We reserve the letter X
for use if the primer does not allow any distinction of
subfamily members. Yand Z can be used to designate subsets
of possible subfamily members and these must be defined.
These designations will be specific for the primers used and
once defined can be used over and over. An example of V
gene identification is shown in Supplementary Table 1.
Identifying other chains Additional examples of using the
nomenclature for human α-TCR, β-TCR, γ-TCR, and
δ-TCR are shown in Table 5. Since the δ-chain could be the
result of either Vδ-o rV α-chain genes rearranging to Jδ,w e
show an example of the naming of both such possibilities
(examples 4 and 5).
TGT   gcc   agt   agt   atT CGG AGT AGc   tac   gag   cag   tac   TTC GGG
  C a       s s      I       R      S S y e q      y      F      G 
1456
Clonotype Identifier              sIRSSy.1456B19S1B27L11
BV19S1  NDN BJ2S7
 Length       1 2      3 4     5       6       7      8       9      10 11
Fig. 1 An example of TCR β-chain clonotype identifier. The BVand
the BJ regions are fully identified. The single-letter -code amino acid
translation is shown below the nucleotide sequence.T h ebold
uppercase letters represent the conserved amino acids from the V
(C) and from the J (FG). The amino acids that are not completely
encoded by the germline, which are predominantly encoded by the
NDN, are also in uppercase (IRSS). Below the NDN-encoded amino
acids is the codon ID for each of them as assigned from the Table 1.
The bold underlined lowercase letters represent the last amino acid
that is completely encoded by the V gene (s) and the first amino acid
that is completely encoded by the J region (y). The clonotype
identifier takes the uppercase NDN amino acids and flanks them with
the lowercase V and J encoded amino acids. This is followed by the
codon ID for the uppercase NDN sequence. The V and J chains are
next identified. Finally, the length of the CDR3 is determined by
counting the number of amino acids between the uppercase C and
uppercase FG. This count is shown in the top line
Table 5 Examples of human TCR α, β, γ, and δ clonotype identifiers
 TCR  V  Gene  NDN  TCR J Gene  Clonotype Identifier 
α  TGT gct tat agg a  CG  agt gga  ggt agc aac tat aaa ctg aca TTT GGA  
A.A.     C     a    y    r  T  s    g      g    s     n   y    k    l     t      F      G  rTs.4A38S2A53L13 
coding   4    
β  TGC agc gt  G AAG GAC GGG GC  t ggg  tac acc TTC GGT  
A.A.     C     s    V        K       D       G      A                                           g     y    t      F       G  sVKDGAg.42241B29S1B12L09 
coding                   4           2        2        4       1    
γ  TGT gcc ttg tgg gag gtg    caa gag ttg ggc aaa aaa atc aag gta TTT GGT  
A.A.      C     a    l   w    e     v         q    e     l    g     k    k     i    k     v     F       G      vq.G09G3L14
coding
δ TGT gac acc TGG GGG AG c t c ct g gg a ca c cc g ac a ga t gt t tTTC GGA
A.A. C d t WG S s wd tr q m fFG tWGSs.146D2D3L13
coding 146
δ TGT gac atg aga g CG GTG T ac acc gat aaa ctc atc TTT GGA
A.A C dmr AV Yt dkl i FG rAVYt.442A14S1D1L08
coding 44 2
The top row of each block is the nucleotide sequence of the TCR chain, middle row is the amino acid translation, and bottom row is the assigned
number for the amino acids that are not completely encoded by the germline gene. The uppercase underlined letters (shown in bold) represent the
conserved amino acids from the V region (C) and the J region (F), and the amino acids that are not completely encoded from the germline gene.
The lowercase underlined letters (shown in bold) represent the last amino acid that is completely encoded by V gene and the first amino acid that
is completely encoded by J gene
498 Immunogenetics (2009) 61:493–502Decoding TCR clonotype identifier By decoding the name,
the nucleotide sequence of the TCR chain can be derived in
a reverse manner as that used for the encoding. Using the
first example shown in Table 5 “rTs.4A38S2A53L13”, the
“A38S2” and “AJ53” shows that the clonotype origin is
human and the sequences of the alpha V38S2 and alpha J53
genes are needed for the decoding (Fig. 2). The entire
length between the “C” and “FG” is 13 amino acids long.
So the genomic sequence of the TCR AV38S2 is obtained
and the positions of the amino acids lined up with a length
ruler starting with the position immediately after the
conserved cysteine. The TCR AJ53 is then placed so that
the last amino acid before the conserved FG lines up with
the end of length ruler. The two lowercase letters “r” and
“s” in the name identify the last V and the first J position
encoded by the germline. This leaves one position to be
filled by the N nucleotides and this is the threonine
represented in the clonotype name as “T”. The codon table
shows that the codon 4 for T is ACG. The Tcan be encoded
entirely by N nucleotides (ACG) or the initial nucleotide, a,
could be V-germline-encoded and the rest of the sequence
is N derived. While Fig. 2 uses the second possibility
(aCG), the sequence is decoded regardless.
D regions
Our nomenclature does not define the D region of the
clonotype. The D regions could be defined after decoding
by a homology search. Because of the truncation of D
regions, they are often difficult to unambiguously assign.
Defining the D region usage would be left to the individual
investigator.
Properties of the naming system
The nomenclature described here has a number of impor-
tant properties:
1. The nomenclature is exhaustive: it ensures that each
clonotypes has an identifier.
2. The nomenclature is compact: an identifier is relatively
short.
3. The nomenclature is an open system in that the
identifiers are not restricted. Therefore, it allows
expansion or addition of identifiers.
4. The nomenclature is compartmental allowing manipu-
lation of identifiers. Manipulations could be sort, select,
arrange, etc. Single or combinations of identifiers can
be manipulated.
Advantages of the naming system
By having these characteristics, the nomenclature has
several general advantages. By combining all five elements
of the CDR3 region, this system permits any clonotype to
be defined. Our nomenclature is more compact than either a
nucleotide- or amino-acid-based naming system. It is two-
thirds shorter than the CDR3 nucleotide sequences, while
still describing the nucleotide sequence. The CDR3 amino
acid sequence is pared to the NDN contribution only. It
distinguishes clonotypes that use different encoding for the
same CDR3 amino acid sequence. For example, we have
found 207 different clonotypes that use the same BV19S1
and the same BJ2S7, and have the exactly the same CDR3
amino acid sequence (CASSIRSSYEQYF). Even if the
amino acid identifier of the name is the same without
nucleotide identifier, it is impossible to distinguish between
them. We show some examples of this in Table 6 from our
analysis of the HLA-A2-restricted response to influenza
M158–66. This shows the power of the nomenclature for
defining population studies that deal with a large number of
similar clonotypes.
By being compartmental, the proposed nomenclature can
enumerate all possible names. Each compartment is an
identifier. While it is unlikely that new J or V regions will
be uncovered in mice or man, these could be easily
absorbed into the name. The compartmentalization allows
the level of identification of the V region to reflect in the
name. If the identification of polymorphic variants of either
V or J regions becomes important, the size of the
compartment for these regions could be expanded to
AV38S2
TGT gct tat agg agc  g
C     a      y r        s AJ53 
L13 =   1      2       3       4      5     6       7      8       9     10    11    12    13
ag aat agt gga ggt agc aac tat aaa ctg aca TTT GGA
                                 n      s     g       g      s       n      y k       l t      F     G
codon ID 
TGT gct  tat agg aCG agt gga ggt agc aac tat   aaa ctg aca TTT GGA
C     a     y r Ts       g       g      s       n      y k       l t      F  G
rTs.4A38S2A53L13 
T 4 
ACG 
Fig. 2 Deriving the nucleotide sequence of the CDR3 by decoding
the clonotype TCR β-chain identifier. The genomic sequence of the
TCRV gene (AV38S2) is obtained and the positions of the amino acids
lined up with a length ruler starting with the position immediately
after the conserved cysteine. The TCRJ gene (AJ53) is then placed so
that the last amino acid before the conserved FG lines up with the end
of length ruler. The two lowercase letters “r” and “s” in the name
identify the last V and first J position encoded by germline. This
leaves one position to be filled by the N nucleotides and this is the
threonine represented as “T” in the clonotype name. The codon table
shows that codon 4 for T is ACG, and the only way that the T can be
encoded is that the initial nucleotide, A, is from the V germline
sequence and the rest of the sequence is N derived
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naming of BCR, an identifier for the heavy chain constant
region could be added after the J identifier. The structure
allows these identifiers to be fully computable and the
character assignment of gene identifier makes it easy to sort
based on the V gene, J gene, and the length. It also supports
a built-in error checking for the digits in ID and number of
amino acids in the NDN region, which is a one to one
relation for all functional TCR clones. For example, if there
are four amino acids in the NDN region, there would be
four-digit numbers in the ID part of the name and the errors
are easily found.
Table 6 Examples of different human clonotype sequences coding identical amino acids in the CDR3β
CDR3 Amino
Acid Sequence TCR V Gene NDN TCR J Gene  Clonotype  Identifier
TGT gcc agt agt ata AGA AG C tcc tac gag cag tac TTC GGG 
CASSIRSSYEQYF    C      a    s    s    i  R      S         s   y    e     q    y      F      G                                          iRSs.56B19S1B27L11
5       6
TGT gcc agt agt at  T CGC AG  C tcc tac gag cag tac TTC GGG 
CASSIRSSYEQYF    C      a    s    s    I  R     S          s   y    e     q    y      F      G                                                     sIRSs.126B19S1B27L11
                             1  2       6 
TGT gcc agt agt ata  AGG AGC AGT  tac gag cag tac TTC GGG 
CASSIRSSYEQYF    C      a    s    s    i  R       S       S                y    e     q    y      F      G                              iRSSy.665B19S1B27L11
6        6       5 
TGT gcc agt agt at  T CGG AGC TCT  tac gag cag tac TTC GGG 
CASSIRSSYEQYF    C      a    s    s    I  R       S       S                y    e     q    y      F      G                        sIRSSy.1461B19S1B27L11
                             1  4       6        1   
TGT gcc agt ag  C ATC AGA AG  C tcc tac gag cag tac TTC GGG 
CASSIRSSYEQYF    C      a    s   S  I       R       S          s   y    e     q    y      F      G                                                     sSIRSs.6256B19S1B27L11
                       6  4       6        1 
TGT gcc agt agt at  T AGA TCC AGC TAT  gag cag tac TTC GGG 
CASSIRSSYEQYF    C      a    s    s    I  R       S        S       Y                     e     q    y      F      G                                                          sIRSSYe.15261B19S1B27L11
                             1  5        2        6        1 
TGT gcc agt ag   C ATA AGG TCC AG  C tac gag cag tac TTC GGG 
CASSIRSSYEQYF    C      a    s   S  I       R        S       S y    e     q    y      F      G                                                          sSIRSSy.63626B19S1B27L11
                       6  3       6        2        6
The top row of each block is the nucleotide sequence encoding CDR3, middle row is the amino acid translation, and bottom row is the assigned
number for the amino acids that are not completely encoded by the germline gene. The uppercase underlined letters (shown in bold) represent the
conserved amino acids from the V region (C) to the J region (F), and the amino acids that are not completely encoded from the germline gene. The
underlined lowercase letters (shown in bold) represent the last amino acid that is completely encoded by the V gene, and the first amino acid that
is completely encoded by the J gene
Table 7 Identifiers of the HLA-A2.1:M158–66-specific clones/clonotypes found in multiple studies
Clonotype identifier Moss et al. 1991
(Clone ID)
Lehner et al. 1995
(Clone ID)
Naumov et al. 1998
(Clonotype ID)
Naumov et al. 2006
(Clonotype ID)
sIRSs.146B19S1B27L11 DDD8 132 19.27
iRSs.66B19S1B27L11 1a8 71 16.27
sIRSs.226B19S1B27L11 B1b MODG5
iRSt.62B19S1B22L11 B1c
sIRs.24B19S1B23L11 B1d
sMRSs.166B19S1B27L11 JNJ1 43.27
iRSSy.626B19S1B27L11 NMH8
sIRSAy.2662B19S1B27L11 KEF9 94 28.27
sTRs.23B19S1B23L11 HLE19 13.23
sMRSs.163B19S1B27L11 MODG4
sMRs.16B19S1B23L11 JN5K2
Different HLA-A2.1 individuals were recruited in the studies reported as Naumov et al. (1998) and (Naumov et al. (2006). The numbers of
individuals sharing identical influenza M158–66-specific clonotypes are shown in the first column. The clonotype identifiers are shown in second
column. The identifiers of the M158–66-specific CD8 T cell clones reported by Moss et al. (1991) and Lehner et al. (1995) and clonotypes reported
by Naumov et al. (1998) and Naumov et al. (2006) are shown in the corresponding columns, respectively
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are public (1), they can be identified in many
laboratories. Thus, a fixed nomenclature will avoid
difficulties associated with local identifiers. For exam-
ple, the M1 response in HLA-A2 individuals has been
studied by many groups. We show that some of the
published clonotypes identified by Moss et al. in 1991
and by Lehner et al. in 1995, and us (Naumov et al. 1998,
2006) were observed in more than one study (Table 7).
This shows the power of a common robust naming system
in comparing the results of related studies that have been
published independently.
Alternative codon numbering systems We also examined an
alternative approach for codon numbering. We used the
same codon numbering table, as described above, but then
generated a list of all the possible ways for encoding of a
particular NDN sequence. The observed sequence is then
defined by its index position on the list. The IRSS amino
acid sequence could be used as an example: when the
clonotype identifier encodes I1 R1, S1, S1, ID number
would be 1 instead of 1111. When the clonotype identifier
encodes I1 R1, S1, S2, ID number would be 2 instead of
1112. Since IRSS has 648 possible encoding combinations
(3×6×6×4), the identifiers would be shorter using one to
three characters. However, the disadvantage of using this
approach is that it is less direct and requires a computer
program for optimal implementation. This takes away the
ability for an individual to manually identify or decode a
particular sequence.
Summary We have implemented a rational nomenclature
system that makes the TCR sequences easier to read and
compare. The nomenclature rules are simple and easy to
implement. Having the codon table available, it would be
easy to name any TCR clonotype or clone without
developing customized naming software. Nevertheless, the
rules are simple enough to be encoded in computer
programs. It has a built-in error-checking system which is
the one to one correspondence between each digit in ID and
each uppercase amino acid in the clonotype identifier. The
benefits of our consistent nomenclature would accrue
exponentially as the number of TCR under the study
increases.
Implementing this nomenclature would facilitate deploy-
ment of clonotype databases run by individual laboratories
for specific immune responses and immune diseases. The
clonotype names within these databases would be reliable,
error-free, and allow easy cross-referencing and comparison
of T cell repertoires by different laboratories. The clono-
types could be cataloged in a single database and annotated
as to their occurrence and associations with particular
responses. Such a catalog is only possible by providing an
easy-to-use nomenclature. T cell clones can be unambigu-
ously identified by naming both chains. The same identi-
fication could be provided for single-cell PCR data where
both chain sequences are available. The framework of this
naming system could also be implemented for B cell
receptors if a system was added to account for somatic
hypermutation. Such a convention would open up the
possibility of creating a BCR catalog which would be a
useful tool for investigators working on BCR repertoires.
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